비오피오이드 진통 패치 시장 : 패치 유형, 적응증, 유통별 - 세계 예측(2025-2030년)

The Non-opioid Pain Patches Market was valued at USD 701.29 million in 2023, expected to reach USD 790.97 million in 2024, and is projected to grow at a CAGR of 12.88%, to USD 1,637.77 million by 2030.

The non-opioid pain patch market focuses on products designed to alleviate pain through transdermal delivery of medications and alternative therapies, avoiding the use of opioids. These patches are crucial for addressing the growing demand for safer pain management solutions amid opioid addiction crises. They find applications in various settings, from chronic pain management to post-operative care, making them versatile in end-use environments such as hospitals, clinics, and home care. Market growth is propelled by an increasing prevalence of chronic pain disorders, advancements in formulation technologies, and heightened awareness of non-addictive pain relief solutions. Key opportunities lie in expanding the user base through awareness campaigns about non-opioid options, partnerships with healthcare providers for wider adoption, and leveraging technology for next-generation patches that enhance drug delivery efficiency. However, the market faces challenges such as stringent regulatory requirements, high development costs, and competition from traditional pain relief methods. Amid these challenges, crucial innovation areas include developing novel patch materials that improve adhesion and comfort, as well as exploring the integration of digital health features for personalized pain management. For market sustenance and growth, companies should focus on building strong R&D capabilities, optimizing supply chains to reduce costs, and engaging in strategic collaborations for market penetration. Transitioning trends towards preventive healthcare and personalized medicine present significant growth avenues, highlighting the importance of market education and evidence-based validation of patch efficacy. It's essential that market players navigate regulatory landscapes adeptly and adapt to evolving consumer preferences for holistic and minimally invasive treatments to sustain competitiveness. Deciphering these dynamics will enable companies to strategize effectively, overcoming growth barriers and capturing emerging opportunities in the evolving non-opioid pain management sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Chronic and Acute Pain-Related Disorders
  • Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
  • Benefits Associated with Non-opioid Pain Patches over Conventional Medications
• Market Restraints
  • Limited Awareness Associated with Non-opioid Pain Patches
• Market Opportunities
  • Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
  • Rising R&D in Pain Management Treatments
• Market Challenges
  • Significant Side Effect Coupled with Availability of Alternative Treatments

Porter's Five Forces: A Strategic Tool for Navigating the Non-opioid Pain Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-opioid Pain Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-opioid Pain Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-opioid Pain Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-opioid Pain Patches Market

A detailed market share analysis in the Non-opioid Pain Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-opioid Pain Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-opioid Pain Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-opioid Pain Patches Market

A strategic analysis of the Non-opioid Pain Patches Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-opioid Pain Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Patch Type, market is studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches.
• Based on Indication, market is studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-Herpetic Neuralgia.
• Based on Distribution, market is studied across Drug Stores, Hospitals, and Online Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
    • 5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
    • 5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
    • 5.1.3.2. Rising R&D in Pain Management Treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Non-opioid Pain Patches Market, by Patch Type

• 6.1. Introduction
• 6.2. Capsaicin Patches
• 6.3. Diclofenac Patches
• 6.4. Ketoprofen Patches
• 6.5. Lidocaine Patches
• 6.6. Methyl Salicylate Patches

7. Non-opioid Pain Patches Market, by Indication

• 7.1. Introduction
• 7.2. Arthritis
• 7.3. Back Pain
• 7.4. Fibromyalgia
• 7.5. Migraines & Headaches
• 7.6. Muscle Strain & Sprains
• 7.7. Post-Herpetic Neuralgia

8. Non-opioid Pain Patches Market, by Distribution

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. Hospitals
• 8.4. Online Pharmacies

9. Americas Non-opioid Pain Patches Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Non-opioid Pain Patches Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Non-opioid Pain Patches Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bridges Consumer Healthcare, LLC
• 2. Cardinal Health, Inc.
• 3. Endo International plc
• 4. GlaxoSmithKline Plc.
• 5. Hisamitsu Pharmaceutical Co., Inc.
• 6. Johnson & Johnson Services, Inc.
• 7. Pfizer Inc.
• 8. Sanofi S.A.
• 9. SCILEX Pharmaceuticals Inc.
• 10. Sorrento Therapeutics, Inc.
• 11. Teh Seng Pharmaceutical Mfg. Co., Ltd.
• 12. Teikoku Seiyaku Co. Ltd.
• 13. Teva Pharmaceutical Industries Ltd.
• 14. Veridian Healthcare
• 15. Virpax Pharmaceuticals, Inc.